• Reliable Lab Workflows with WP1066, JAK2/STAT3 Inhibitor, Ce

  2026-05-26

  This article addresses common laboratory challenges in cell-based assays, focusing on the practical deployment of WP1066, JAK2/STAT3 inhibitor, cell-permeable (SKU A4140). Drawing on peer-reviewed evidence and validated protocols, it guides biomedical researchers toward reproducible, data-backed outcomes in cancer and regenerative medicine workflows.

• Propranolol: Benchmarking a Non-Selective β-Adrenergic Block

  2026-05-26

  Propranolol is a non-selective β-adrenergic receptor blocker with proven efficacy in cardiovascular regulation, emotional memory modulation, and metabolic research. Its dual action on β1 and β2 receptors is supported by robust quantitative and mechanistic data.

• Pioglitazone: Applied PPARγ Agonist Workflows & Assay Insigh

  2026-05-25

  Pioglitazone stands out as a selective PPARγ agonist for dissecting inflammatory and metabolic mechanisms in translational research. This article delivers stepwise workflows, troubleshooting tactics, and data-driven guidance for maximizing assay performance and reproducibility.

• HAUS1 Expression and Immune Microenvironment in Hepatocellul

  2026-05-25

  This study establishes HAUS1 as a diagnostic and prognostic biomarker in hepatocellular carcinoma (HCC), linking its overexpression to poor patient outcomes and altered immune microenvironment. Integrating bioinformatic analyses with functional assays, the paper highlights HAUS1's role in cell proliferation and its potential as a therapeutic target.

• Midecamycin: Applied Workflows for Macrolide Antibiotic Rese

  2026-05-24

  Midecamycin empowers microbiology labs to dissect bacterial protein synthesis with precision, especially in Gram-positive strains. This guide translates its unique mechanism and reference-backed data into actionable assay workflows, troubleshooting strategies, and advanced applications for reproducible, high-impact research.

• GSK621 in Immunometabolic Research: AMPK Agonism Beyond AML

  2026-05-23

  Explore the scientific depth of GSK621 as an AMPK agonist, highlighting its unique mechanistic insights and translational potential in immunometabolic research. This article reveals new perspectives on assay design, autophagy, and apoptosis induction using GSK621.

• Triacetin Metabolism: Insights into Short-Chain Triacylglyce

  2026-05-22

  This study elucidates the rapid digestion and absorption mechanisms of triacetin, a short-chain triacylglycerol, in rats. The findings reveal that triacetin is completely hydrolyzed in the upper gastrointestinal tract, with its metabolites modulating hepatic gene expression and energy metabolism, offering new perspectives for metabolic disorder research.

• Dabigatran (Pradaxa) in Advanced Thrombin Inhibition Assays

  2026-05-22

  Dabigatran (Pradaxa) enables precise, reproducible thrombin inhibition and advanced coagulation function testing, outclassing traditional anticoagulants through its rapid, reversible mechanism. This article details applied workflows, protocol enhancements, and troubleshooting strategies for leveraging APExBIO's Dabigatran (SKU A4077) in bench research.

• Losmapimod: Dual-Action p38 MAPK Inhibition Decoded for Tran

  2026-05-21

  Delve into the dual-action mechanism of Losmapimod, a potent p38 MAPK inhibitor, and discover how new structural insights refine inflammation signaling modulation and vascular research. This article uniquely dissects practical assay implications for GW856553X in translational workflows.

• Salvianolic Acid A Targets GOT2 to Reduce Doxorubicin Cardio

  2026-05-21

  This study uncovers the mechanism by which salvianolic acid A protects against doxorubicin-induced cardiotoxicity by directly targeting glutamic-oxaloacetic transaminase 2 (GOT2) and activating the malate-aspartate NADH shuttle. These findings suggest new strategies for mitigating cardiac oxidative injury in oncology and cardiovascular research.

• High-Dose Bifendate Induces Acute Hypertriglyceridemia in Ro

  2026-05-20

  This study rigorously demonstrates that oral administration of high-dose bifendate (DDB) acutely elevates serum and hepatic triglyceride (TG) levels in rabbits and mice. The resulting hypertriglyceridemia is dose-dependent and transient, highlighting both novel utility and caution for researchers modeling lipid metabolism and liver injury.

• Hydroxychloroquine Mitigates CTX-Induced Ovarian Failure via

  2026-05-20

  This study demonstrates that hydroxychloroquine (HCQ) protects against cyclophosphamide (CTX)-induced premature ovarian failure by reducing granulosa cell senescence through inhibition of the mtDNA-cGAS signaling pathway. These findings provide mechanistic insight into HCQ's potential to preserve ovarian function amidst chemotherapeutic stress, with implications for fertility preservation strategies.

• Grazoprevir Hydrate: Precision Protocols for HCV Replication

  2026-05-19

  Grazoprevir hydrate (MK-5172 hydrate) empowers researchers to model hepatitis C virus replication inhibition with unrivaled precision, even in challenging settings like HIV/HCV coinfection or chronic kidney disease. This guide details advanced workflows, troubleshooting, and protocol enhancements, ensuring robust, reproducible results with APExBIO’s trusted quality.

• STING Pathway Links Conjugated Bile Acids to Liver Disease P

  2026-05-19

  This study reveals that conjugated bile acids exacerbate cholestatic liver diseases by inducing cholangiocyte senescence via the STING signaling pathway. Integrating human and mouse model data, the research uncovers mitochondrial damage, inflammatory crosstalk, and molecular heterogeneity, highlighting STING as a promising therapeutic target.

• LINC01278 Suppresses Uveal Melanoma via mTOR-Related Autopha

  2026-05-18

  The study identifies LINC01278 as a tumor-suppressive lncRNA in uveal melanoma, acting through induction of autophagy by inhibition of the mTOR signaling pathway. These findings clarify the mechanistic interplay between lncRNAs, autophagy, and tumor progression, and suggest new approaches for therapeutic intervention in UM.

453 records 17/31 page Previous Next First page 上5页 1617181920 下5页 Last page